Why Metabolically Healthy People Are Tracking Their Blood Sugar: The Science of CGMs

For decades, keeping tabs on blood sugar was the exclusive domain of people managing diabetes. But a quiet shift in wearable technology has transformed the continuous glucose monitor (CGM) from a specialized medical device into a mainstream tool for metabolic optimization. Following the FDA's 2024 approval of over-the-counter CGMs for non-diabetics, the small white patches have become increasingly visible on the arms of athletes, executives, and wellness enthusiasts. The appeal lies in the promise of real-time, personalized data. Instead of waiting for an annual physical to get a single snapshot of metabolic health, users can watch their body's internal chemistry react minute-by-minute to a bowl of oatmeal, a stressful meeting, or a poor night of sleep.[7]

A continuous glucose monitor works by inserting a microscopic filament just beneath the skin, typically on the back of the upper arm or the abdomen. Rather than measuring blood directly, the sensor measures glucose levels in the interstitial fluid—the fluid that surrounds the body's cells. The device takes a reading every few minutes and transmits the data via Bluetooth to a smartphone app, creating a continuous line graph of the user's metabolic state. Most sensors are water-resistant, painless to apply, and last for 10 to 14 days before they need to be replaced. For people without diabetes, this constant stream of data offers a window into a physiological process that is usually entirely invisible until something goes wrong.[3]

The central argument for non-diabetic CGM use stems from the limitations of standard medical testing. During a routine physical, doctors typically assess metabolic health using two metrics: fasting blood glucose and Hemoglobin A1c (HbA1c). Fasting glucose provides a snapshot of blood sugar after a night of not eating, while HbA1c estimates the average blood sugar level over the previous three months. While these tests are excellent for diagnosing clinical diabetes, longevity experts argue they are backward-looking metrics that miss the early, subtle signs of metabolic dysfunction. A patient can have a perfectly normal fasting glucose and A1c while still experiencing massive, damaging spikes in blood sugar throughout the day.[1]

To understand why averages fall short, physicians often use a driving analogy. If one car drives at a steady 50 miles per hour, and another car wildly accelerates to 100 miles per hour before slamming on the brakes to hit zero, both cars have an average speed of 50 miles per hour. However, the wear and tear on the second car's engine and brakes will be vastly different. The same principle applies to the human vascular system. Two people can share an identical, healthy A1c of 5.2%, but one might have a stable "flat" glucose profile, while the other experiences a daily rollercoaster of severe spikes and crashes. Standard blood panels cannot differentiate between the two.[1][6]

This rollercoaster effect is clinically known as glycemic variability, and a growing body of evidence suggests it matters deeply for long-term health. Dr. Peter Attia, a prominent longevity physician, has argued extensively that high glucose variability in non-diabetics is independently associated with an accelerated onset of chronic disease. Frequent, severe spikes in blood sugar drive chronic low-grade inflammation, increase oxidative stress, and contribute to arterial damage over time. Prospective studies have linked this high variability to an increased risk of cardiovascular disease, Alzheimer's disease, and all-cause mortality, leading many preventative medicine advocates to conclude that flattening the glucose curve is a crucial pillar of longevity.[1]

Beyond disease prevention, CGMs have upended decades of generic nutritional advice by revealing the sheer scale of individual biological variation. For years, dietitians relied on the Glycemic Index to predict how certain foods would affect blood sugar. But a landmark study published in the journal Cell by researchers Eran Elinav and Eran Segal tracked 800 participants and found that individual glycemic responses to identical foods varied enormously. The researchers discovered that a person's unique gut microbiome, genetics, and lifestyle factors dictate their metabolic response far more than the carbohydrate content of the food itself.[5]

The practical implications of this individual variation are profound. In the Cell study, researchers observed that a standard bowl of oatmeal might cause a negligible glucose rise in one participant, while sending another participant's blood sugar soaring into pre-diabetic ranges. Conversely, the second participant might eat a banana with zero adverse metabolic effect, while the first participant experiences a massive spike. This data suggests that the concept of a universally "healthy" diet is fundamentally flawed. By wearing a CGM, individuals can map their own unique "glucotype" and tailor their nutrition to their specific biology, rather than relying on generalized food pyramids.[5]

The insights provided by continuous monitoring extend far beyond the kitchen. The 2025 CGM-HYPE study, published in PLOS Digital Health, monitored healthy young adults through controlled dietary, exercise, and stress challenges. The researchers found that psychological stress and poor sleep profoundly degrade the body's ability to manage carbohydrates. A meal that produces a gentle, healthy glucose curve after a full eight hours of sleep might trigger a severe, prolonged spike if the user is sleep-deprived or facing a high-pressure deadline at work. For many biohackers, seeing the undeniable, quantified impact of stress on their metabolic health becomes the ultimate catalyst for prioritizing sleep and recovery.[4]

The data also highlights physiological nuances that can easily confuse new users, particularly regarding exercise. High-intensity anaerobic workouts—like sprinting or heavy weightlifting—often cause a sharp spike in blood sugar. Without context, a user might view this spike as a negative event. In reality, this is a healthy, adaptive response: the liver is rapidly dumping stored glycogen into the bloodstream to fuel the intense muscular effort. Unlike a spike caused by eating a donut, an exercise-induced spike is not driven by a lack of insulin sensitivity and does not carry the same long-term inflammatory risks.[4]

Perhaps the most powerful benefit of CGM use in healthy populations is its role as a behavioral feedback loop. Real-time data has a unique ability to drive habit change. When a user sees their blood sugar climbing rapidly after a heavy lunch, they are highly motivated to take action. Studies have shown that nearly half of healthy CGM users report that seeing a high glucose reading increases their likelihood of taking a brisk 15-minute walk, which effectively blunts the spike by allowing muscles to absorb the excess glucose independent of insulin. This immediate accountability loop turns abstract health advice into a tangible, gamified daily practice.[1][4]

Despite the enthusiasm from the biohacking community, the mainstream medical establishment remains highly skeptical of widespread CGM use for healthy individuals. Experts at institutions like Harvard Medical School point out a glaring gap in the literature: there are currently no long-term randomized controlled trials proving that continuous glucose monitoring actually improves health outcomes or extends lifespan in non-diabetics. While the physiological theories regarding glycemic variability are sound, skeptics argue that optimizing a system that is already functioning properly may be a waste of time, money, and mental energy.[2][3]

Furthermore, researchers studying wearable health data warn that providing clinical-grade diagnostics to the general public can cause unnecessary anxiety. The user interfaces of most CGM apps were originally designed for diabetics, featuring bright red warning alerts when blood sugar crosses certain thresholds. For a healthy person, a temporary spike to 160 mg/dL after eating a slice of pizza is a normal physiological response, not a medical emergency. Nutritionists have raised concerns that hyper-fixating on these numbers can lead to "pathological stress," orthorexia, and the avoidance of perfectly healthy foods like fruit and legumes simply because they cause a natural, temporary rise in glucose.[3]

Technical limitations also complicate the interpretation of consumer CGM data. The sensors measure interstitial fluid, which lags behind actual blood glucose by roughly 10 to 15 minutes. Additionally, even the best consumer devices have a Mean Absolute Relative Difference (MARD) of roughly 8 to 9 percent, meaning a reading of 100 mg/dL could actually be anywhere from 91 to 109. Users also frequently experience "compression lows"—false alarms triggered in the middle of the night simply because the person rolled over and slept on the sensor, restricting the fluid flow around the filament.[3]

To help clinicians and users separate signal from noise, researchers have worked to define what a "normal" CGM profile actually looks like. A multicenter prospective study published in the Journal of Clinical Endocrinology & Metabolism tracked 153 healthy, non-diabetic participants across various age groups. The study found that healthy individuals spend an average of 96 percent of their day with their glucose in the target range of 70 to 140 mg/dL. They also found that brief excursions above 140 mg/dL are entirely normal, accounting for about 30 minutes of an average healthy person's day.[6]

Given the balance of benefits and drawbacks, a consensus is emerging among preventative medicine practitioners regarding the optimal use of CGMs for non-diabetics. Rather than wearing the devices perpetually, many experts recommend a short-term "discovery phase" of two to four weeks, repeated perhaps once or twice a year. This limited window provides ample time to identify personal dietary triggers, understand the impact of sleep and stress, and establish new habits, without the financial burden or psychological fatigue of constant, year-round tracking.[1][7]

Ultimately, continuous glucose monitors represent a significant leap forward in the democratization of personal health data. They offer an unprecedented, individualized look at how our daily choices impact our internal chemistry, moving nutrition away from generic guidelines and toward precision biology. While they are not a magic bullet—and certainly not a replacement for the foundational pillars of a healthy diet and regular exercise—they serve as a powerful, illuminating tool for those looking to take an active, data-driven role in their long-term metabolic health.[7]